TrialScientific reports2018

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing.

Christian Schoergenhofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.